跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LABETALOL HYDROCHLORIDE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LABETALOL HYDROCHLORIDE INJECTION USP
Authorized
STANDARD
LABETALOL HYDROCHLORIDE INJECTION USP
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
18265ba3d60442ce
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
18265ba3d60442ce
Drug Approval Canada Name
LABETALOL HYDROCHLORIDE INJECTION USP
Product Name
LABETALOL HYDROCHLORIDE INJECTION USP
Status
Marketed
Status Date
2021-05-26
Original Market Date
2021-05-26
Din
02385120
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
24:24.00
Atc Original
C07AG01 LABETALOL
Atc Name
c 07 ag 01
Aig Number
0116170002
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
LABETALOL HYDROCHLORIDE
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
18265ba3d60442ce
Type
Standard
Back to Health Canada Approvals